Fluoxetine HCl-Loaded Nanostructured Lipid Carriers for Nose-to-Brain Delivery: Optimization and Synergistic Role of Saffron Oil
Journal of Molecular Neuroscience · 2025
DOI: 10.1007/s12031-025-02411-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, 2025. Verfasst von Avinash R Tekade und 5 weiteren Autor:innen. Beteiligte Einrichtung: Marathwada Mitra Mandal's College of Pharmacy, Thergaon (Kalewadi), Pune, 411033, M.S.), India. avitekade@gmail.com. Hauptthemen laut MEDLINE: Drug Carriers, Fluoxetine, Nanostructures, Plant Oils. Die Arbeit nennt 70 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Depression is a widespread psychiatric condition marked by ongoing sadness, disinterest, insomnia, and thoughts of self-harm. Fluoxetine HCl (FH) is a frequently prescribed antidepressant; however, it has low oral bioavailability (28%) due to significant first-pass metabolism and has side effects such as low blood pressure, gastrointestinal discomfort, and blurred vision. This research aimed to create and assess a novel intranasal nanostructured lipid carrier (NLC) system for FH, utilizing saffron oil (SO) as a functional lipid to enhance brain delivery while minimizing systemic side effects. METHODS: FH-NLCs were prepared using the high-pressure homogenization and ultrasonication method and was optimized based on particle size, PDI, Drug loading and entrapment efficiency. RESULTS: The observed mean particle size of FH-NLCs is 117.3 nm, PDI 0.219, and ZP -44.76 mV which were ideal for nose-to-brain delivery. The optimized formulation showed high drug loading and entrapment efficiency. Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) confirmed a uniform morphology, while X-ray diffraction (XRD) and differential scanning calorimetry (DSC) indicated partial amorphization of the drug within the lipid matrix. The in vitro drug release exhibited a sustained profile without burst release, adhering to Korsmeyer-Peppas kinetics, which showed non-fickian diffusion Super Case II Transport (n = 1.14). Ex vivo permeation studies on goat nasal mucosa revealed significantly enhanced nasal mucosal permeability compared to the FH solution, indicating the permeation-enhancing properties of SO. Histopathological assessments confirmed the formulation's safety for nasal application. The pharmacodynamic evaluations demonstrated a synergistic antidepressant effect between FH and SO, thereby supporting improved therapeutic efficacy. CONCLUSION: The intranasal delivery of FH through SO-based NLCs offers a promising approach for direct brain targeting, potentially enhancing clinical outcomes in depression while reducing systemic side effects of FH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marathwada Mitra Mandal's College of Pharmacy, Thergaon (Kalewadi), Pune, 411033, M.S.), India. avitekade@gmail.com.
- Marathwada Mitra Mandal's College of Pharmacy, Thergaon (Kalewadi), Pune, 411033, M.S.), India.
Zitieren
APA
Tekade, A. R., Kadam, P. V., Aswar, M. K., Gaikwad, A. B., Shinde, R. B., & Kharade, S. S. (2025). Fluoxetine HCl-Loaded Nanostructured Lipid Carriers for Nose-to-Brain Delivery: Optimization and Synergistic Role of Saffron Oil. Journal of Molecular Neuroscience. https://doi.org/10.1007/s12031-025-02411-x
Vancouver
Tekade AR, Kadam PV, Aswar MK, Gaikwad AB, Shinde RB, Kharade SS. Fluoxetine HCl-Loaded Nanostructured Lipid Carriers for Nose-to-Brain Delivery: Optimization and Synergistic Role of Saffron Oil. Journal of Molecular Neuroscience. 2025. doi:10.1007/s12031-025-02411-x
BibTeX
@article{Tekade2025,
author = {Tekade, Avinash R and Kadam, Prasad V and Aswar, Manoj K and Gaikwad, Anil B and Shinde, Rohit B and Kharade, Snehal S},
title = {Fluoxetine HCl-Loaded Nanostructured Lipid Carriers for Nose-to-Brain Delivery: Optimization and Synergistic Role of Saffron Oil},
journal = {Journal of Molecular Neuroscience},
year = {2025},
doi = {10.1007/s12031-025-02411-x}
}
EUVIMED